• Reveromycin A, EvoPure� packaged and labeled in glass vial.

click on thumbnail to zoom
SKU: R022

  Click 'Bulk Order' for 10 or more
Price: make selection(s)
Reveromycin A, the dominant analogue of a complex of spiroketals isolated from a Streptomyces sp., is an inhibitor of the mitogenic activity of EGF. Reveromycin A displays antiproliferative behaviour against human cell lines KB and K562, as well as potent antifungal activity. More recently it has been shown to induce apoptosis in osteoclasts thus inhibiting bone resorption.

Reveromycin A is soluble in ethanol, methanol, DMF and DMSO.

    CAS Number


    Molecular Formula


    Molecular Weight


    Mechanism of Action

    Reveromycin A is a G1 phase cell cycle inhibitor, selectively inhibiting isoleucyl-tRNA synthetase.

    Storage Conditions




    Tan Lyophilisate



    Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Woo J.T. et al. Proc Natl Acad Sci USA. 2006, 103, 4729.

    Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Muguruma H. et al. Clin Cancer Res. 2005, 11, 8822.

    Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A. Miyamoto Y., et al. , J. Biol. Chem., 2002, 277, 28810. 

    Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. Takahashi H., et al. , J. Antibiot., 1992, 45, 1414.

Other Items In This Category